News Category
A nurse's personal battle with metastatic triple-negative breast cancer underscores the importance of understanding new treatments like antibody-drug ...
In a Novartis-sponsored discussion, a prostate cancer patient and a Prostate Cancer Foundation expert highlight the importance of PSMA testing for gui...
Heidelberg Pharma and Huadong Medicine have received NMPA approval for a Phase Ib/II trial of HDP-101 in combination therapies for relapsed/refractory...
A new peer-reviewed study published in Critical Care Medicine shows that VolitionRx's Nu.Q NETs H3.1 biomarker independently predicts 28-day mortality...
Novogenia's U.S. launch of the MGT Plus methylation test expands genetic analysis to 27 genes across six pathways, potentially impacting personalized ...
Citius Pharmaceuticals is transitioning to a commercial-stage biopharma with FDA-approved LYMPHIR generating revenue, while advancing late-stage candi...
Annovis Bio announced a corporate update webinar for September 2, discussing its Phase 3 Alzheimer's trial, open-label studies, and regulatory milesto...
A new study suggests a personalized mRNA vaccine can prevent melanoma recurrence for years, offering hope for cancer treatment.
Creative Biolabs announces a webinar featuring Dr. Greg M. Delgoffe to discuss modeling T cell dysfunction in the tumor microenvironment, highlighting...
Dr. David Zelby, a Marietta prosthodontist with over 40 years of experience, has been named a 2026 Castle Connolly Top Dentist, an honor given to only...
A new T cell therapy could transform treatment for recurrent glioblastoma, a disease with few effective options, offering new hope for patients.
VERAXA Biotech and Secarna's early in vitro results show their AOC candidate is more potent than unconjugated oligonucleotides, supporting the approac...
VERAXA Biotech has moved its VXA-222 bispecific antibody-drug conjugate program into the next development stage after completing the initial OmniAb co...
The Keith Dagostino Scholarship for Cancer Survivors opens applications, offering financial aid to undergraduate cancer survivors across the U.S. to r...
VERAXA Biotech received favorable Scientific Advice from Germany's Paul-Ehrlich-Institute for its lead BiTAC-TCE cancer therapy, potentially reducing ...
VERAXA Biotech's proprietary BiTAC platform aims to improve cancer therapy precision, with lead programs advancing toward regulatory activities and a ...
Onco-Innovations has entered a non-binding LOI with Ifowonco Informatics to potentially acquire an exclusive option on a small-molecule LAG-3 inhibito...
A new study reveals that nearly 80% of young adults have early signs of cardiovascular-kidney-metabolic syndrome, linking advanced stages to arterial ...
Quantum BioPharma is advancing a novel MS treatment focusing on myelin protection, potentially addressing disease progression that current therapies m...
A mathematical study published in Mathematical Business proposes a solution to melanoma therapy resistance, potentially improving treatment outcomes f...
Quantum BioPharma's FDA-cleared phase 2 trial of Lucid-MS highlights a shift in MS treatment toward protecting the nervous system, addressing an unmet...
VERAXA Biotech's collaboration with Ardigen aims to use AI to identify optimal dual-target combinations for cancer therapies, potentially reducing dev...
Researchers have identified a protein on glioblastoma cells that could be targeted to make the cancer more vulnerable to existing treatments, potentia...
NanoViricides expects to begin a Phase II clinical trial of its oral antiviral NV-387 for Ebola in the DRC, potentially offering a more accessible tre...
The 20th Annual Sickle Cell Disease Educational Summit, hosted by Cayenne Wellness Center, will celebrate two decades of progress in treatment and adv...
Helix BioPharma Corp. has appointed Dr. Markus Loeffler as Chief Medical Officer to lead its clinical development programs, including the upcoming Pha...
The summit aims to address the unique challenges faced by Hispanic and Latino individuals with sickle cell disease through culturally relevant educati...
LCFA and IASLC fund two promising scientists with $200,000 each to advance research on lung microbiome's role in cancer and metabolic pathways in drug...
A new memoir by Maria Cristina Swiman tells the true story of a Brazilian mother's harrowing journey across Brazil, Europe, and the U.S. to reunite wi...
A comprehensive review published in World Journal of Pediatric Surgery synthesizes current evidence on surgical management of necrotizing enterocoliti...
Helix BioPharma reshapes its board with the resignation of Janusz Grabski and appointment of CEO Thomas Mehrling, aiming to align governance with clin...
Onco-Innovations is progressing its biomarker-driven cancer therapy ONC010 through key manufacturing and metabolic studies, positioning it for first-i...
Researchers at the University of Manchester have discovered that a subset of immune cells, often overlooked, is essential for mobilizing the immune sy...
Lantern Pharma reported Q2 2026 results, highlighting progress in its AI-driven oncology pipeline and the establishment of Open Medicine AI as a separ...
NeOnc Technologies' NEO100 met its primary endpoint in a Phase 2a trial for recurrent brain cancer, showing improved progression-free survival and ove...
GeoVax highlights its MVA-based hemorrhagic fever vaccine candidates as the Bundibugyo Ebola outbreak in Congo becomes the fastest-growing on record, ...
Kyle Brown of Brown & Hobkirk, PLLC attended ALS Arizona's Bite Nite gala and is organizing a golf tournament to support the nonprofit, highlighting t...
NanoViricides has received regulatory approval to begin a Phase II trial of its oral antiviral NV-387 for Ebola, potentially offering a more accessibl...
University of Virginia scientists find focused ultrasound may make brain tumors more susceptible to cancer drugs, offering a targeted approach that co...
Telomir Pharmaceuticals announced peer-reviewed preclinical data showing Telomir-Zn suppresses tumor growth in prostate and triple-negative breast can...
A comprehensive review in the World Journal of Pediatric Surgery offers a unified framework for diagnosing and treating neuroblastoma, emphasizing ris...
Quantum BioPharma is progressing its two-pronged approach to neurological health, targeting multiple sclerosis with Lucid-MS and alcohol-related effec...
A case in Spain where a patient's pork tapeworm infection mimicked brain cancer highlights the dangers of undercooked pork and the urgent need for imp...
VERAXA Biotech has advanced its VXA-222 bispecific antibody-drug conjugate into the next development stage and expanded its IP portfolio, strengthenin...
The Keep A Breast Foundation's 2026 High Desert Collection merges art and community to promote breast health awareness, with exhibitions in Pioneertow...
A novel liquid biopsy offers a simpler way to predict which advanced lung cancer patients will respond to immunotherapy, potentially improving treatme...
GeoVax announced completion of manufacturing, regulatory, clinical, and preclinical milestones for its mpox/smallpox vaccine GEO-MVA, supporting initi...
Onco-Innovations is combining PNKP-targeted therapy, nanoparticle delivery, and AI to develop ONC010, aiming to improve cancer treatment efficacy and ...
